How much does Erlotinib cost?
The cost for erlotinib oral tablet 25 mg is around $1,388 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
What is the brand name for Erlotinib?
Erlotinib is a type of targeted cancer drug, and is also known by its brand name Tarceva (pronounced tar-see-vah). It is a treatment for: non small cell lung cancer (NSCLC) that has spread (advanced) advanced pancreatic cancer – alongside the chemotherapy drug gemcitabine.
What is Erlotinib used for?
Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better.
What is the most common side effect of Erlotinib?
The most common adverse reactions with TARCEVA are rash and diarrhea usually with onset during the first month of treatment. The incidences of rash and diarrhea from clinical studies of TARCEVA for the treatment of NSCLC and pancreatic cancer were 70% for rash and 42% for diarrhea.
What does Tarceva cost?
The cost for Tarceva oral tablet 25 mg is around $2,874 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
When was erlotinib approved?
Conclusions: On November 18, 2004, the FDA granted erlotinib regular approval for treatment of patients with locally advanced or metastatic NSCLC after failure of at least one prior chemotherapy regimen.
Does erlotinib cause vision changes?
Eye Concerns: While receiving erlotinib, some patients may develop irritation or damage to the cornea (clear part covers the eyeball) or changes in your eyesight. Notify your healthcare team if you develop any eye pain, swelling, redness or any vision changes, including blurriness and sensitivity to light.
Who makes erlotinib?
Genentech: Tarceva® (erlotinib) – Information for Patients.
What type of drug is erlotinib?
Erlotinib. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche. In the United States as of 2015 one 150 mg pill costs between 200 and 242 USD.
What is erlotinib (Iressa)?
Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). The drug follows Iressa ( gefitinib ), which was the first drug of this type. Erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase , which is highly expressed and occasionally mutated in various forms of cancer.
How long does it take for Erlotinib to work?
Resistance to treatment Erlotinib bound to ErbB1 at 2.6A resolution; surface colour indicates hydrophobicity. As with other ATP competitive small molecule tyrosine kinase inhibitors, such as imatinib in CML, patients rapidly develop resistance. In the case of erlotinib this typically occurs 8–12 months from the start of treatment.
Is erlotinib a JAK2 inhibitor?
Erlotinib was shown to be a potent inhibitor of JAK2V617F activity. JAK2V617F is a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia.